Science Corp CEO Max Hodak Predicts End of Screen Era
· marketing
The Interface Revolution: Science Corp’s Vision for a Post-Screen Era
At TechCrunch Disrupt 2026, Max Hodak, CEO of Science Corporation, will argue that the screen-based world is slowly coming to an end. This vision has become an all-consuming passion project for Hodak, who believes that brain-computer interface technology can revolutionize human-machine interaction.
Science Corp’s technology bypasses traditional interfaces by directly interpreting brain signals. This allows machines to adapt to our thoughts, needs, and behaviors. The company’s PRIMA implant has already shown remarkable results in restoring eyesight for those with severe vision loss. Hodak envisions a future where this technology is used not only to treat medical conditions but also to enhance human capabilities.
Hodak’s journey to developing brain-computer interface technology began when he started programming at six years old. He worked alongside Miguel Nicolelis’ groundbreaking brain-computer interface lab and co-founded Neuralink, which brought brain implants into the public consciousness. His experience has prepared him for the ambitious goals of Science Corporation.
The implications of this technology extend far beyond creating new interfaces. It holds the potential to revolutionize healthcare by healing damaged brain cells, detecting seizures, and treating conditions such as Parkinson’s disease. The tech industry may also see a wave of innovation in fields like AI, healthcare, and finance, where brain-computer interfaces could unlock new forms of data analysis.
However, this raises important questions about ethics and social implications. Will we need to redefine what it means to be “human” in an era where machines are increasingly integrated into our lives? How will we balance the benefits of advanced neural engineering with potential risks to personal data security and autonomy?
Despite these concerns, Hodak’s vision is compelling, especially considering Science Corp’s significant funding – a $1.5 billion valuation on a $230 million Series C round. This isn’t just some concept; it’s a tangible vision for how we interact with machines – and each other.
As attendees at TechCrunch Disrupt 2026 will soon learn, Hodak is not just proposing a new era but also outlining the steps to get there. His argument is that the current screen-based world is no longer sufficient and that brain-computer interfaces offer a more intuitive way of interacting with technology. Hodak’s vision may be ambitious, but it has already secured significant funding, indicating that investors believe in its potential.
The question remains: are we ready to take the leap into this brave new world?
Reader Views
- MDMateo D. · small-business owner
While Max Hodak's vision of a post-screen era is intriguing, I'm still waiting for concrete answers on how brain-computer interfaces will be secured against hacking and surveillance. Will we have to sacrifice some level of personal autonomy in exchange for the convenience of thought-controlled devices? As someone who's had to deal with cybersecurity breaches at my own business, I know that these concerns shouldn't be swept under the rug. A more nuanced discussion about the implications of this technology on individual freedom is necessary before we can fully buy into its potential.
- TSThe Stage Desk · editorial
Hodak's grand vision for a post-screen era is nothing short of audacious, but his tunnel vision on brain-computer interfaces overlooks the elephant in the room: energy efficiency. As these implants proliferate, we'll need to account for the sheer power consumption required to sustain them. Can Science Corp truly revolutionize human-machine interaction without sacrificing our already strained global resources?
- ABAriana B. · marketing consultant
While Max Hodak's vision of a post-screen era is undeniably exciting, we can't afford to overlook the crucial issue of accessibility in brain-computer interface technology. Will this revolutionary tech be available and affordable for the masses, or will it exacerbate existing healthcare disparities? Science Corporation needs to prioritize inclusivity and transparency around pricing and distribution models to avoid perpetuating the same exclusivity that characterizes many cutting-edge technologies today.